HomeMedical Oncology

Medical Oncology

Physician insights on cancer treatment protocols, immunotherapy, targeted therapies, and clinical trial updates.

Recent Discussions

Would you discontinue anticoagulation in patients with antiphospholipid antibody syndrome, who have a remote history of thrombotic events and are now negative for pathogenic antiphospholipid antibodies?

3 Answers

Mednet Member

Rheumatology · Hackensack University Medical Center

I would certainly consider stopping anticoagulation in selected patients after an in-depth discussion about potential risks and benefits. I would not consider stopping AC in patients with a history of recurrent events, arterial events, or multiple risk factors for thrombosis (e.g. nephrotic syndrome...

Are there best practices or data regarding the use of open notes among oncology patients?

2 Answers

Mednet Member

Medical Oncology · Mayo Clinic Rochester

The 21st Century Cures Act regulation (effective April 2021) required that clinical notes such as consult and office notes be shared with patients, e.g. “open notes.” In general, surveys of patients with cancer and their clinicians suggest that open notes are viewed favorably (Salmi et al., PMID 330...

Medical Oncology

Recent Discussions

Would you discontinue anticoagulation in patients with antiphospholipid antibody syndrome, who have a remote history of thrombotic events and are now negative for pathogenic antiphospholipid antibodies?

Are there best practices or data regarding the use of open notes among oncology patients?

Noelle K. LoConte, MD

Stephen V. Liu, MD

Sara M. Tolaney, MD, MPH

Lawrence H. Einhorn, MD

John C. Byrd, MD

Anthony Bejjani

Elizabeth Henry

John Baird